History

2017 Apr.

Truxima™ launched in Europe (EMA approved)

2016

Dec.
Remsima™ expected to be launched in U.S. (FDA approved)

2015

Feb.
Remsima™ launched in Canada (Health Canada approved)

2014

Nov.
Remsima™ launched in Japan (MHLW approved)

2013

Nov.
Remsima™ launched in Europe (EMA approved)

2012

Oct.
Remsima™ launched in Korea (MFDS approved)

2009

Dec.
Global distribution network established (Partnership over 120 countries by 2016)
Mar.
Nexol, Inc. renamed as Celltrion Healthcare Co., Ltd.

2008

Aug.
Nexol, Inc. and Celltrion, Inc. established Global distribution agreement

2002

Feb.
Celltrion, Inc. founded (A global biologics company)

1999. Dec.

Dec.
Nexol, Inc. founded (Business management consulting)